Methods for enhancing the effect of EGCg on mitigating skeletal muscle loss

Patent metadata

Field	Value
Publication number	US-9579347-B2
Application number	US-201314433538-A
Country	US
Kind code	B2
Filing date	Oct 4, 2013
Priority date	Oct 4, 2012
Publication date	Feb 28, 2017
Grant date	Feb 28, 2017

Abstract

Disclosed herein are methods for enhancing the efficacy of epigallocatechin gallate (“EGCg”) in mitigating skeletal muscle loss in a subject. Providing EGCg to a subject in a nutritional composition reduces muscle protein degradation, thereby mitigating skeletal muscle loss in the subject. The combination of EGCg with zinc in a nutritional composition enhances the mitigating effect that EGCg has on muscle loss. Specifically, when used in combination, a nutritional composition containing both EGCg and zinc requires less EGCg to obtain the same mitigating effect that occurs in the same nutritional composition containing EGCg but no zinc.

First claim

The invention claimed is:

1. A method for enhancing the efficacy of epigallocatechin gallate (EGCg) in mitigating skeletal muscle loss in a subject in need thereof or for reducing the amount of epigallocatechin gallate (EGCg) required to decrease skeletal muscle loss due to aging, inactivity, or disease in a subject in need thereof, the method comprising:
providing to the subject in need thereof at least one serving per day of a nutritional composition, the nutritional composition comprising:
at least one source of EGCg in an amount sufficient to provide 10-1000 mg of EGCg per serving;
at least one source of zinc in an amount sufficient to provide 2.5-30 mg of zinc per serving; and
at least one source of protein in an amount sufficient to provide 5-50 g of protein per serving;
whereby consumption of at least one serving per day of the nutritional composition results in decreased skeletal muscle loss in the subject as compared to the consumption of a comparative composition containing no zinc.

2. The method of claim 1 , wherein the nutritional composition is a liquid nutritional product having a serving size ranging from 150 mL to 500 mL.

3. The method of claim 1 , wherein the total amount of EGCg per serving is 125-500 mg and the total amount of zinc per serving is 5-20 mg.

4. The method of claim 1 , wherein the at least one source of EGCg comprises green tea extract that contains 30-100 weight % of EGCg.

5. The method of claim 1 , wherein the at least one source of EGCg further comprises at least one of a catechin (C), a gallocatechin (GC), an epicatechin (EC), an epicatechin gallate (ECg), an epigallocatechin (EGC), and combinations thereof.

6. The method of claim 1 , wherein the at least one source of zinc is a zinc salt selected from the group consisting of zinc sulfate, zinc gluconate, zinc iodide, zinc chloride, zinc citrate, zinc carbonate, zinc hydroxide, zinc lactate, zinc acetate, zinc fluoride, zinc bromide, zinc sulfonate, zinc glucuronate, and combinations thereof.

7. The method of claim 1 , wherein the at least one source of protein is selected from the group consisting of whey protein concentrates, whey protein isolates, whey protein hydrolysates, acid caseins, sodium caseinates, calcium caseinates, potassium caseinates, casein hydrolysates, milk protein concentrates, milk protein isolates, milk protein hydrolysates, nonfat dry milk, condensed skim milk, soy protein concentrates, soy protein isolates, soy protein hydrolysates, pea protein concentrates, pea protein isolates, pea protein hydrolysates, collagen proteins, and combinations thereof.

8. The method of claim 1 , wherein the nutritional composition further comprises an ingredient selected from the group consisting of at least one source of carbohydrates, at least one source of fat, and combinations thereof.

9. The method of claim 1 , wherein the nutritional composition has a calorie content of 50-500 kcal per serving.

10. The method of claim 1 , wherein the nutritional composition is a clear liquid nutritional product having a pH of 2-5 and having no more than 0.5 weight % fat based on the total weight of the nutritional composition.

11. The method of claim 1 , wherein the nutritional composition is a liquid nutritional product and further comprises at least one source of carbohydrates and at least one source of fat, and wherein per serving:
the at least one source of protein provides 10-50% of the calories,
the at least one source of carbohydrates provides 20-85% of the calories, and
the at least one source of fat provides 5-50% of the calories.

12. The method of claim 1 , wherein the glycemic index of the nutritional composition is less than or equal to 50.

13. The method of claim 1 , whereby administration of at least one serving per day of the nutritional composition results in sustained or improved muscle function in the subject as compared to the administration of a comparative composition containing no zinc.

14. The method of claim 1 , wherein the nutritional composition further comprises at least one source of a compound selected from the group consisting of leucine, isoleucine, valine, glycine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan, carnitine, carnosine, creatine, alpha-ketoisocaproate, and combinations thereof.

15. The method of claim 1 , wherein the nutritional composition further comprises at least one source of a compound selected from the group consisting of beta-hydroxy-beta-methylbutyrate, beta-alanine, and combinations thereof.

16. The method of claim 1 , wherein the molar ratio of zinc to EGCg ranges from 0.1:1 to 2:1.

17. A method for reducing the amount of epigallocatechin gallate (EGCg) needed to mitigate skeletal muscle loss attributable to aging, inactivity, or disease in a subject in need thereof, the method comprising:
providing a serving of a liquid nutritional composition to the subject at least once a day, the nutritional composition including the following ingredients based on a 150 mL to 500 mL serving size:
at least one green tea extract in an amount sufficient to provide 10-1000 mg of EGCg per serving;
at least one source of zinc in an amount sufficient to provide 2.5-30 mg of zinc per serving; and
at least one source of protein in an amount sufficient to provide 5-50 g of protein per serving,
whereby consumption of the nutritional composition results in less skeletal muscle loss in the subject as compared to the consumption of a comparative composition containing no zinc.

18. A method for reducing the amount of epigallocatechin gallate (EGCg) required to sustain or improve skeletal muscle function in a subject in need thereof, due to age, inactivity, or disease, the method comprising:
providing to the subject a nutritional composition containing a combination of 10-1000 mg of EGCg and 2.5-30 mg of zinc,
whereby consumption of the nutritional composition requires less EGCg to sustain or improve skeletal muscle function as compared to the consumption of a comparative composition containing no zinc.

19. The method of claim 18 comprising providing at least one serving per day of the nutritional composition to the subject, wherein the nutritional composition is a liquid nutritional composition having a serving size ranging from 150 mL to 500 mL.

20. The method of claim 18 , wherein the nutritional composition includes an ingredient selected from the group consisting of at least one source of protein, at least one source of carbohydrates, at least one source of fat, and combinations thereof, and
wherein the nutritional composition has a calorie content of 50-500 kcal per serving.

Assignees

• Abbott Lab

Inventors

• Pereira Suzette
• Garvey Sean
• Edens Neile

Classifications

• A61P21/06

  Anabolic agents (androgens A61P5/26) · CPC title

• A61P21/00

  Drugs for disorders of the muscular or neuromuscular system · CPC title

• A23L33/40

  Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

• A23L33/16

  Inorganic salts, minerals or trace elements · CPC title

• A61K9/0095

  Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006) · CPC title